1. Quantitative determination of eight active constituents in Tibetan medicine Zuozhudaxi by HPLC
Chinese Traditional and Herbal Drugs 2014;45(15):2189-2193
Objective: To establish an HPLC method for the simultaneous determination of eight components in Tibetan medicine Zuozhudaxi, and improve the standard of HPLC test. Methods: The HPLC analysis was performed on a Kromasil C18 column (250 mm×4.6 mm, 5 μm). The column temperatrue was set at 30℃. A mixture of methyl alcohol-0.05% phosphoric acid aqueous solution was used as the mobile phase, gradient eluted with the flow rate at 1 mL/min, and detected by different UV wave lengths, i.e. 225 nm for gallic acid, benzoic acid, kaempferol, costunolide, and dehydroepiandrosterone costunolide, 352 nm for chlorogenic acid, and 445 nm for crocin I and crocin II. Results: The eight components were well separated with ideal linear correlations. The average recoveries were in the range of 97.13%-101.42%. The contents of the eight components between two manufactures were different. PLS-DA loading plot of the samples showed that gallic acid, benzoic acid, kaempferol, dehydroepiandrosterone costunolide, and crocin II were the main components which made contributions to the quality of Zuozhudaxi. Conclusion: The method is reliable, stable, accurate, and reproducible for the quantitative determination and quality control of Zuozhudaxi.
2.A study on the long-term outcome of hepatitis B e antigen-negative chronic hepatitis B compared with that of hepatitis B e antigen-positive chronic hepatitis B
Gui-Cheng WU ; Wei-Ping ZHOU ; You-Tong ZHAO ; Shu-Hua GUO ; Ai-Long HUANG ; Hong REN ; Ding-Feng ZHANG ;
Chinese Journal of Infectious Diseases 2001;0(03):-
0.05)between the two groups.Conclu- sion The long-term outcomes of e-CHB is not markedly different compared with that of e+CHB.
3.Covert lung abscess as a cause of atrial arrhythmia: case report.
Mei LI ; De-ning LIAO ; Jia-you ZHANG ; Ren-fu YIN ; Zong-gui WU
Chinese Medical Journal 2005;118(14):1227-1229
4.Antitumor efficacy of the recombinant Newcastle disease virus rNDV-IL15 on melanoma models.
Ze-Shan NIU ; Fu-Liang BAI ; Tian SUN ; Hui TIAN ; Jie-Chao YIN ; Hong-Wei CAO ; Dan YU ; Gui-You TIAN ; Yun-Zhou WU ; De-Shan LI ; Gui-Ping REN
Acta Pharmaceutica Sinica 2014;49(3):310-315
In order to enhance the antitumor efficacy of recombinant Newcastle disease virus, rNDV-IL15 was rescued in this study. Recombinant plasmid prNDV-IL15 was constructed, and BHK21 cells were transfected with the recombinant plasmid. Finally, the recombinant Newcastle disease virus rNDV-IL15 was successfully rescued. The growth curves of these two recombinant viruses were determined. Murine melanoma B16F10 cells were infected with rNDV-IL15 at MOI of 0.1, and the expression level of IL15 in the supernatant was detected by ELISA. The antitumor efficacy of rNDV-IL15 and rNDV was compared in vitro and in vivo. Results showed that prNDV-IL15 was constructed and recombinant virus rNDV-IL15 was successfully rescued. The growth curve of rNDV-IL15 showed that the growth of rNDV-IL15 had not been changed after insertion of IL15 gene. Results showed that there was high level of IL15 expression in the supernatant of rNDV-IL5-infected B16F10 cells (1 044.3 +/- 27.7 ng x mL(-1)). rNDV-IL15 and rNDV significantly inhibited the growth of B16F10 cells in vitro in a time-dependent manner. However, there was no significant difference between them. In animal experiments, rNDV-IL15 efficiently suppressed tumor growth in vivo when compared with rNDV, and the difference was statistically significant. The results suggested that rNDV-IL15 is a more effective antitumor agent.
Animals
;
Body Weight
;
Cell Line, Tumor
;
Cell Proliferation
;
Chick Embryo
;
Cytotoxicity, Immunologic
;
Female
;
Genetic Therapy
;
Interleukin-15
;
genetics
;
metabolism
;
Melanoma, Experimental
;
pathology
;
therapy
;
Mice
;
Neoplasm Transplantation
;
Newcastle disease virus
;
genetics
;
Plasmids
;
Recombinant Proteins
;
genetics
;
metabolism
;
Transfection
;
Tumor Burden
5.Antitumor activity of the recombinant rClone30-CD/5-FC system.
Zheng LU ; Tian-Yuan ZHANG ; Miao-Miao HAN ; Fu-Liang BAI ; Wei WU ; Gui-You TIAN ; Gui-Ping REN ; De-Shan LI
Acta Pharmaceutica Sinica 2013;48(2):261-268
5-Flucytosine (5-FC) could be changed to 5-fluorouracil (5-FU) by cytosine deaminase (CD), the latter is able to kill cancer cells. However, there is no efficient method to deliver the CD gene into the tumor cells, which hampers the application of the suicide gene system. In this experiment, for the first time, the NDV has been utilized as a vector to deliver the CD gene into the cancer cells, the virus can infect the cancer cells specifically, replicate and assemble, while the cytosine deaminase is expressed. Then the CD converts the prodrug 5-FC into 5-FU to achieve the purpose of inhibiting tumor. Firstly, the whole genome of E. coli JM109 was extracted, and the CD gene was obtained by cloning method. Then the CD and IRES-EGFP were ligated into the pEE12.4 expression vector to become a recombinant pEE12.4IE-CD eukaryotic expression plasmid. The human liver cancer cells were transfected with the plasmid. The cells were treated with different concentrations of 5-FC, MTT method was used to determine the killing effect of CD/5-FC system on the human liver cancer cells. The cell deaths were 18.07%, 42.98% and 62.20% respectively when the concentrations of prodrug were at 10, 20 and 30 mmol x L(-1). In 5-FC acute toxicity experiment, Kunming mice were injected with different concentrations of 5-FC at intervals of 1:0.5. The LD50 of 5-FC through iv injection was determined by improved Karber's method, the LD50 was 507 mg x kg(-1) and the 95% confidence limit was 374-695 mg x kg(-1). According to the maximum LD0 dose of the LD50, the maximum safe dose was 200 mg x kg(-1). Body weight and clinic symptoms of the experimental animals were observed. These results laid the foundation to verify the antitumor effect and safety of CD/5-FC system in animal models. The CD gene was ligated into the NDV (rClone30) carrier, then the tumor-bearing animal was established to perform the tumor inhibiting experiment. The result showed that the recombinant rClone30-CD/5-FC system has a high antitumor activity in vivo. To summarize, CD gene has been cloned and its bioactivity has been confirmed in the mammalian cells. It is the first time in this study to utilize the recombinant NDV to deliver the CD gene into the tumor cells; our result proves the rClone30-CD/5-FC system is a potential method for cancer therapy.
Animals
;
Antimetabolites, Antineoplastic
;
metabolism
;
pharmacology
;
Cell Death
;
drug effects
;
Chick Embryo
;
Cytosine Deaminase
;
genetics
;
metabolism
;
Escherichia coli
;
genetics
;
metabolism
;
Flucytosine
;
metabolism
;
pharmacology
;
Fluorouracil
;
metabolism
;
pharmacology
;
Genetic Vectors
;
Hep G2 Cells
;
Humans
;
Lethal Dose 50
;
Liver Neoplasms, Experimental
;
pathology
;
Mice
;
Newcastle disease virus
;
genetics
;
Plasmids
;
Recombinant Proteins
;
genetics
;
metabolism
;
Transfection
;
Tumor Burden
;
drug effects
6.Effect of FGF-21 on learning and memory ability and antioxidant capacity in brain tissue of D-galactose-induced aging mice.
Yin-Hang YU ; Gui-Ping REN ; Yao-Nan LIU ; Su-Su QU ; Fu-Liang BAI ; Tong ZHANG ; Wen-Fei WANG ; Gui-You TIAN ; Xian-Long YE ; De-Shan LI
Acta Pharmaceutica Sinica 2014;49(7):1000-1006
This study aims to investigate the effects of fibroblast growth factor 21 (FGF-21) on learning and memory abilities and antioxidant capacity of D-galactose-induced aging mice. Kunming mice (37.1 +/- 0.62) g were randomly divided into normal control group, model group and FGF-21 high, medium and low dose groups (n = 8). Each group was injected in cervical part subcutaneously with D-galactose 180 mg x kg(-1) x d(-1) once a day for 8 weeks. At the same time, FGF-21-treated mice were administered with FGF-21 by giving subcutaneous injection in cervical part at the daily doses of 5, 2 and 1 mg x kg(-1) x d(-1). The normal control group was given with normal saline by subcutaneous injection in cervical part. At seventh week of the experiment, the learning and memory abilities of mice were determined by water maze and jumping stand tests. At the end of the experiment, the mice were sacrificed and the cells damage of hippocampus was observed by HE staining in each group. Reactive oxygen species (ROS), malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT) and total antioxidant capacity (T-AOC) in the brain of mice were determined. The results showed that different doses of FGF-21 could reduce the time reaching the end (P < 0.01 or P < 0.05) and the number of touching blind side (P < 0.01 or P < 0.05) in the water maze comparing with the model group. It could also prolong the latency time (P < 0.05) and decrease the number of errors (P < 0.01 or P < 0.05) in the step down test. The result of HE staining showed that FGF-21 could significantly reduce brain cell damage in the hippocampus. The ROS and MDA levels of three different doses FGF-21 treatment group reduced significantly than that of the model group [(5.58 +/- 1.07), (7.78 +/- 1.92), (9.03 +/- 1.77) vs (12.75 +/- 2.02) pmol (DCF) x min(-1) x mg(-1), P < 0.01 or P < 0.05], [(2.92 +/- 0.71), (4.21 +/- 0.81), (4.41 +/- 0.97) vs (5.62 +/- 0.63) nmol x mg(-1) (protein), P < 0.01]. Comparing with the model group, the activities of SOD, GPx, CAT and T-AOC of the three different doses FGF-21 treatment groups were also improved in a dose-dependent manner. This study demonstrates that FGF-21 can ameliorate learning and memory abilities of D-galactose induced aging mice, improve the antioxidant abilities in brain tissue and delay brain aging. This finding provides a theoretical support for clinical application of FGF-21 as a novel therapeutics for preventing aging.
Aging
;
drug effects
;
Animals
;
Antioxidants
;
metabolism
;
Brain
;
drug effects
;
Catalase
;
metabolism
;
Fibroblast Growth Factors
;
pharmacology
;
Galactose
;
Glutathione Peroxidase
;
metabolism
;
Hippocampus
;
drug effects
;
Malondialdehyde
;
metabolism
;
Maze Learning
;
drug effects
;
Memory
;
drug effects
;
Mice
;
Superoxide Dismutase
;
metabolism
7.The synergism and mechanism of action of rClone30-hDR5 in combination with TRAIL on HCC.
Tian SUN ; Ze-Shan NIU ; Xue-Ying LIU ; Gui-You TIAN ; Yin BAI ; Fu-Liang BAI ; Jie-Chao YIN ; Dan YU ; Yun-Zhou WU ; De-Shan LI ; Qing-Zhong YU ; Si-Ming LI ; Gui-Ping REN
Acta Pharmaceutica Sinica 2014;49(7):985-992
To investigate the cell-killing effect and its possible mechanism of rClone30-hDR5 in combination with TRAIL on human hepatic carcinoma (HCC) cell line, first of all, recombinant plasmid pee12.4-hDR5 was introduced into HepG2 cells by liposome transfection. After five rounds of screening by flow cytometry, HepG2 cells expressing high levels of DR5 on cell surface were isolated. The cytotoxicity of TRAIL to selected cells was higher than that of TRAIL to HepG2 cells by MTT method (P < 0.01). The result suggested that the cloned hDR5 gene had biological activity. MTT assay showed that, rClone30- hDR5 in combination with TRAIL more efficiently inhibited the tumor growth of HepG2 cells compared to rClone30-hDR5 or TRAIL in vitro. The results of Annexin V-FITC/PI staining and Quantitative Real-time PCR indicated that rClone30-hDR5 in combination with TRAIL significantly increased the mRNA levels of caspase 3 and caspase 8, and induced the apoptosis of tumor cells. HepG2 cells were infected with rClone30-hDR5 or rClone30 at MOI of 1. The expression of hDR5 on tumor surface increased significantly by rClone30-hDR5 compared to that by rClone30, which contributed to the sensitivity to TRAIL. In conclusion, rClone30-hDR5 in combination with TRAIL has potential application value in cancer treatment.
Apoptosis
;
Carcinoma, Hepatocellular
;
pathology
;
Caspase 3
;
metabolism
;
Caspase 8
;
metabolism
;
Drug Synergism
;
Hep G2 Cells
;
Humans
;
Liver Neoplasms
;
pathology
;
Real-Time Polymerase Chain Reaction
;
Receptors, TNF-Related Apoptosis-Inducing Ligand
;
pharmacology
;
TNF-Related Apoptosis-Inducing Ligand
;
pharmacology
;
Transfection
8.Causes of death after hip fracture in senile patients.
Ren-Shi MA ; Yu ZHANG ; Xu HUANG ; Dong ZHU ; Gui-Shan GU ; Guo-Tao YANG ; Ming LI ; Ai-Hua SONG ; Yang YOU
Chinese Journal of Traumatology 2012;15(1):42-49
Hip trauma has been a leading cause of death in senile patients for more than a centenary. Although the mortality decreased due to the advanced technique in medication, surgery and nursing, the increasing mortality should not be neglected in elders after orthopedic operation nowadays. Many factors are considered to influence the causes of death after trauma, such as age, gender, personal customs, comorbidities, types of fracture, timing of surgery, procedure, anesthesia, complications, medical treatment, activity of daily living, or even marriage status. This article reviews these causes from the aspects of patient's own factors, iatrogenic factors, medical treatment and other factors and provides some clues for further clinical application according to the recent foreign and domestic researches. According to the present research, it is essential for surgeons to perform a comprehensive estimation for patients suffering from hip trauma.
Cause of Death
;
Hip Fractures
;
surgery
;
Humans
;
Orthopedic Procedures
;
Regression Analysis
9.Generation of a herpes simplex virus-permissive mouse melanoma cell line B16RHSV.
Xiu-fen ZHUANG ; Ai-ping ZHOU ; Gui-lan SHI ; Xiang-ping HAN ; Jie LI ; Yu ZHANG ; You-hui ZHANG ; Shu-ren ZHANG ; Bin-lei LIU
Chinese Journal of Oncology 2012;34(3):187-191
OBJECTIVETo generate an oncolytic herpes simplex virus (oHSV) permissive mouse melanoma cell line B16RHSV, preserving the tumorigenic ability in syngeneic mice.
METHODSThe herpes simplex virus entry mediator (HVEM) gene was amplified by PCR from human melanoma cell line A375, and cloned into pGEM-T Easy vector for sequencing. The HVEM gene was then cloned into pcDNA3 vector to generate pcDNA3-HVEM for transfection of mouse melanoma cell line B16-F10 cells. After that, the putative transfected cells were selected in full growth medium containing G418. The HVEM-expressing cells were isolated by immunomagnetic bead separation. The mouse melanoma cell line expressing oHSV receptor-HVEM, designated as B16RHSV, was generated. The permissibility of B16RHSV cells to oHSV infection was examined with green fluorescence protein (GFP)-expressing oHSV (oHSVGFP). To investigate the tumorigenic ability of both cells in vivo, 2×10(5) cells in 100 µl were subcutaneously inoculated into the right flanks of C57/BL mice.
RESULTSIn vitro, the B16RHSV mouse melanoma cells were shown by fluorescence microscopy capable of being infected by oHSVGFP. In vivo, the B16RHSV cells, like their wild type counterpart, grew to form melanoma in syngeneic mice.
CONCLUSIONA herpes simplex virus-permissive mouse melanoma cell line was established. Its tumorigenicity remained unchanged.
Animals ; Cell Line, Tumor ; Female ; Gene Amplification ; Genetic Vectors ; Herpesvirus 1, Human ; genetics ; physiology ; Humans ; Melanoma ; pathology ; virology ; Mice ; Mice, Inbred C57BL ; Neoplasm Transplantation ; Plasmids ; Receptors, Tumor Necrosis Factor, Member 14 ; genetics ; metabolism ; Transfection ; Tumor Burden
10.Long-term health-related quality of life in chronic hepatitis B patients.
Gui-cheng WU ; Wei-ping ZHOU ; You-rong ZHAO ; Shu-hua GUO ; Zhi-yi WANG ; Shu-bi ZOU ; Quan-hai ZHANG ; Hong REN ; Ai-long HUANG ; Ding-feng ZHANG
Chinese Journal of Hepatology 2003;11(5):275-277
OBJECTIVETo evaluate their long-term outcome and the efficacy and economic significance of antiviral drugs by investigating the long-term health-related quality of life (HQL) in chronic hepatitis B (CHB) patients.
METHODSThe HQL of 101 CHB patients with biopsy-proven 6 to 18 years ago and 105 persons of general population as control was studied with revised SF-36 questionnaire.
RESULTSThe HQL in CHB patients was lower than that in general population in physical functioning, role physical, general health, mental health, and specific symptoms (mu > or = 2.10, P<0.05).
CONCLUSIONSThe long-term HQL in chronic hepatitis B patients is poor.
Adolescent ; Adult ; Antiviral Agents ; therapeutic use ; Cost of Illness ; Female ; Follow-Up Studies ; Hepatitis B, Chronic ; drug therapy ; economics ; Humans ; Male ; Middle Aged ; Quality of Life ; Surveys and Questionnaires